CN206476981U - A kind of kit detected for B cell leukemia minimal residual disease - Google Patents

A kind of kit detected for B cell leukemia minimal residual disease Download PDF

Info

Publication number
CN206476981U
CN206476981U CN201720025086.2U CN201720025086U CN206476981U CN 206476981 U CN206476981 U CN 206476981U CN 201720025086 U CN201720025086 U CN 201720025086U CN 206476981 U CN206476981 U CN 206476981U
Authority
CN
China
Prior art keywords
hinged
box
movable block
cell leukemia
residual disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201720025086.2U
Other languages
Chinese (zh)
Inventor
刘聪
雷菁
赵双双
尚小云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Racing Biotechnology Co Ltd
Original Assignee
Wuhan Racing Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Racing Biotechnology Co Ltd filed Critical Wuhan Racing Biotechnology Co Ltd
Priority to CN201720025086.2U priority Critical patent/CN206476981U/en
Application granted granted Critical
Publication of CN206476981U publication Critical patent/CN206476981U/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The utility model discloses a kind of kit detected for B cell leukemia minimal residual disease, including box body, lid is hinged with the box body, placed cavity is provided with the box body, refrigerating box is provided with the placed cavity, in the placed cavity fixed plate is equipped with relative side wall, the fixed plate is provided with the first connector, cylinder is hinged with first connector, the side of the lid is provided with two the second connectors being parallel to each other, the piston-rod end of the cylinder is hinged on the second connector, movable block is provided with the refrigerating box, cavity is provided with the movable block, drive device is provided with the cavity, the output shaft of the drive device is provided with first gear.The function of being implemented in combination with automatically opening up kit that the utility model passes through cylinder, drive device and folded sheet; the setting for placing plate and damping spring etc. simultaneously not only facilitates operation; the effect of damping is also acted as, the reagent bottle of the inside is protected, it is suitable to promote.

Description

A kind of kit detected for B cell leukemia minimal residual disease
Technical field
The utility model is related to biological technical field, more particularly to a kind of B cell leukemia minimal residual disease that is used for is detected Kit.
Background technology
Bone-marrow-derived lymphocyte also can abbreviation B cell.From the multipotential stem cell of marrow.Birds are that life is developed in the bursa of farbricius Into, therefore also known as bursa-dependent lymphocyte/marrow dependence lymphocyte abbreviation B cell, it is by the candidate stem cell in marrow point Change development.Compared with T lymphocytes, its volume is bigger.After this lymphocyte receptor antigenic stimulus, meeting Proliferation, Differentiation goes out A large amount of thick liquid cells.Thick liquid cell can be synthesized with secretory antibody and circulated in blood.B cell lymphoma is a kind of most common lymph Chronic myeloid leukemia, the research about this disease is continued to bring out.In mammality developed in the tissue such as marrow of class capsule structure 's.Also known as bone marrowdependent lymphocyte.The stem cell come from marrow or pre B cell, after the bursa of farbricius or bursa-equivalent organ is moved into, by Step is divided into the B cell of immunological competence.Ripe B cell is moved out through peripheral blood, into spleen, lymph node, is distributed mainly on In lymph nodule under splenic corpuscle, splenic cords and lymph nodule, lymphatic cord and gastrointestinal mucosal, after antigenic stimulus, differentiation and proliferation For thick liquid cell, synthetic antibody plays the function of humoral immunity.The most of vaccines used at present are exactly by stimulating this kind of B to drench Bar cell produces antibody.Quantity of the B cell in marrow and aggregated lymphatic follicles is more compared with T cell, in blood and lymph node Quantity is fewer than T cell, then less in ductus thoracicus, only a small number of to participate in recycling.There are many different marks on the cell membrane of B cell Will, mainly surface antigen and surface receptor.These surface markers are all incorporated in the huge protein molecular on cell membrane.B1 cells For T cell independence cell.B2 is T cell dependent cell.The time that B cell is survived in vivo is shorter, and only a couple of days is to number Week, but its memory cell in vivo can long-term existence, at present to B cell leukemia residual detect when typically use reagent Box is detected that still, existing reagent cartridge configuration is simple, and function is single, only with bearing function, it is impossible to reagent is carried out cold Tibetan is handled, very inconvenient to use with less the function of automatic opening, therefore, being used for B cell leukemia we have proposed one kind The kit of minimal residual disease detection solves the above problems.
Utility model content
The purpose of this utility model is that, in order to solve shortcoming present in prior art, and the one kind proposed is used for B cell The kit of Minimal Residual Disease of Leukemia detection.
To achieve these goals, the utility model employs following technical scheme:
Box is hinged with a kind of kit detected for B cell leukemia minimal residual disease, including box body, the box body It is provided with lid, the box body in placed cavity, the placed cavity and is provided with refrigerating box, is equipped with the placed cavity on relative side wall Fixed plate, the fixed plate is provided with the first connector, first connector and is hinged with cylinder, and the side of the lid is set There are two the second connectors being parallel to each other, the piston-rod end of the cylinder is hinged on the second connector, the refrigerating box Interior be provided with movable block, the movable block is provided with cavity, and drive device, the output shaft of the drive device are provided with the cavity It is provided with to run through on first gear, the movable block and is provided with rotating bar, the two ends of the rotating bar on the outside of movable block is equipped with Roller, the rotating bar in cavity is provided with second gear, first gear and the second gear intermeshing, the refrigeration The chute corresponding with roller is equipped with box on relative side wall, and roller is located in chute, the side of the movable block connects Folded sheet is connected to, the one end of the folded sheet away from movable block is fixed on the side wall in refrigerating box, in the refrigerating box Provided with refrigerating plant.
Preferably, the side of the box body is hinged with loading plate, what the side wall of the box body was parallel to each other provided with two Bobbin winoler, the bobbin winoler is provided with drawstring, and the one end of the drawstring away from bobbin winoler is fixed on loading plate, the loading plate On be equidistantly provided with multiple first standing grooves, the side of first standing groove is provided with two the second standing grooves, and described second puts Groove is put more than the first standing groove.
Preferably, multiple upper cushion blocks, the side of the upper cushion block are equidistantly provided with side wall relative in the placed cavity Damping spring is fixed with, the one end of the damping spring away from upper cushion block is fixed with lower cushion block, and one end of the lower cushion block is fixed On the side wall of refrigerating box.
Preferably, the lid, which is provided with stopper slot, the stopper slot, is hinged with handle, and the handle is provided with anti-skidding Line.
Preferably, it is equipped with heat-insulation layer on the side wall in the refrigerating box.
In the utility model, when being operated, cylinder can be opened lid by the flexible of piston rod, while bobbin winoler is logical Cross drawstring to put down loading plate, drive device drives first gear to rotate by the rotation of output shaft, the rotational band of first gear Dynamic second gear is rotated, so as to drive roller to be slided in chute, and then folded sheet is folded, operating personnel take out of refrigerating box Go out reagent bottle, be positioned in corresponding standing groove and detected according to size, the utility model by cylinder, drive device and The function of being implemented in combination with automatically opening up kit of folded sheet, while the setting for placing plate and damping spring etc. is not only square Operation, also act as the effect of damping, protect the reagent bottle of the inside, it is suitable to promote.
Brief description of the drawings
Fig. 1 be the utility model proposes it is a kind of for B cell leukemia minimal residual disease detect kit structure Schematic diagram;
Fig. 2 be the utility model proposes it is a kind of for B cell leukemia minimal residual disease detect kit inside Structural representation;
Fig. 3 be the utility model proposes it is a kind of for B cell leukemia minimal residual disease detect kit damping Apparatus structure schematic diagram.
In figure:1 lid, 2 loading plates, 3 handles, 4 stopper slots, 5 box bodys, 6 cylinders, 7 fixed plates, 8 bobbin winolers, 9 drawstrings, 10 refrigerating box, 11 damping springs, 12 movable blocks, 13 folded sheets.
Embodiment
Below in conjunction with the accompanying drawing in the utility model embodiment, the technical scheme in the utility model embodiment is carried out Clearly and completely describe, it is clear that described embodiment is only a part of embodiment of the utility model, rather than whole Embodiment.
Reference picture 1-3, a kind of kit detected for B cell leukemia minimal residual disease, is below the utility model The specifically used step of kit:
1st, One step RT-PCR step;
2nd, magnetic beads for purifying step
1) amount for taking out magnetic bead vibration mixing 5min 45 μ l/ samples of taking-up is put in room temperature 10min;
2) RT-PCR product respectively takes out 20 μ l, remaining 5 μ l justincase, then each sample adds 30 μ lH2O, most Magnetic bead is added according to 45 μ l/ afterwards, is inhaled with rifle and blows about 10 mixings, be put in room temperature 2min;
3) uncap and be put in 1min or so on magnetic frame, liquid, which becomes clarification, can wash out liquid, add 125 μ l85% second Wash out and discard after alcohol, 1min, magnetic bead is put in room temperature 8min (5-10min) and dried.
3rd, DNA concentration is determined with Nanodrop.If concentration is 20ng/ μ l, 5 times are diluted;If close to 40ng/ μ l, 10 times of dilution.
4th, end is repaired:Following component (50 μ l) is mixed in 1.5ml centrifuge tubes
1) 34 μ l are purifiedPatient's sample genomeDNA (or moisturizing to 34 μ l)
2) buffer solution is repaired in 5 μ l10 × end
3) 5 μ l2.5mMdNTP mixtures
4)5μl10mMATP
5) 1 μ l ends repair enzyme
Room temperature is placed 45 minutes.Purified with QIAquickPCR purification columns, eluted with 34 μ l buffer solutions.
5th, 3 ' ends add A:Following component (50 μ l) is mixed in 1.5ml centrifuge tubes:
1) DNA after the end of 34 μ l steps 4 is repaired
2) 5 μ lKlenow buffer solutions=NEBbuffer2
3)10μl1mMdATP
4) 1 μ lKlenow fragments (5 prime excision enzyme activities of 3 ' à 5 ')
(1mMdATP with 100mMdATP mother liquors dilute, often the μ l of pipe 25 dispense, can only freeze thawing once)
Purified with MinElutePCR purification columns, the elution of 12 μ l buffer solutions.
6th, joint is connected:Following component (30ul) is mixed in 1.5ml centrifuge tubes
1) DNA of 11 μ l steps 5
2) 15 μ lDNA connection buffer solutions
3)1μl1:The linker oligonucleotides of 20 dilutions
4) 3 μ lDNA ligases
If doing multiple repetitions simultaneously, it is ensured that each parallel reaction adds different joints, marks clear.
7th, gel screening removes unnecessary joint:
The 6 μ l sample-loading buffers for diluting 10 times are added in the reaction solution of the steps of 30 μ l the 6th, loading to two E-gel glue Kong Zhong.The 50bpDNAladder loadings for taking 20 μ l to dilute 10 times in addition.Electrophoresis 20 minutes.
DNA of the size between 150bp to 450bp is cut, is purified with QIAquick gel purification kits,
30 μ l elution buffers are eluted.
8th, Illumina primer PCRs are used:
IlluminaPCR primers 1.1 and 2.1 are carried out 1 with Gibco water:1 is diluted in PCR pipe and mixes following component (60ul):
1) DNA of 30 μ l steps 4
2) 28 μ lPhusionPCR premixed liquids
3) primer 1.1 of 1 μ l dilutions
4) the primer 2 .1 of 1 μ l dilutions
PCR cycle:
9th, molecular weight screening is carried out on 2% Ago-Gel:
The 1 μ l sample-loading buffers diluted are added in the PCR reaction solutions of previous step, loading is into three E-gel glue holes. 50bp the and 100bpDNAladder loadings for taking 20 μ l to dilute 10 times respectively in addition.Electrophoresis 30 minutes.Size is cut in 400bp The DNA of left and right.Purify DNA with QIAquick gel purification kits, eluted with 30 μ l elution buffers.
10th, DNA concentration is determined.Gained DNA concentration is determined with NanoDrop.
In the utility model, when being operated, cylinder 6 can be opened lid 1 by the flexible of piston rod, while coiling Device 8 is put down loading plate 2 by drawstring 9, and drive device drives first gear to rotate by the rotation of output shaft, first gear Rotate and drive second gear to rotate, so as to drive roller to be slided in chute, and then folded sheet 13 is folded, operating personnel are from cold Hide and reagent bottle is taken out in box 10, be positioned in corresponding standing groove and detected according to size.
It is described above, only the utility model preferably embodiment, but protection domain of the present utility model is not This is confined to, any one skilled in the art is in the technical scope that the utility model is disclosed, according to this practicality New technical scheme and its utility model design are subject to equivalent substitution or change, should all cover in protection model of the present utility model Within enclosing.

Claims (5)

1. a kind of kit detected for B cell leukemia minimal residual disease, including box body (5), it is characterised in that the box It is hinged with body (5) in lid (1), the box body (5) and is provided with placed cavity, refrigerating box (10) is provided with the placed cavity, it is described Fixed plate (7) is equipped with placed cavity on relative side wall, the fixed plate (7) is provided with the first connector, and described first connects Cylinder (6) is hinged with fitting, the side of the lid (1) is provided with two the second connectors being parallel to each other, the cylinder Piston-rod end is hinged on the second connector, is provided with the refrigerating box (10) in movable block (12), the movable block (12) Provided with cavity, drive device is provided with the cavity, the output shaft of the drive device is provided with first gear, the movable block (12) run through on and be provided with rotating bar, the two ends of the rotating bar on the outside of movable block (12) are equipped with roller, in cavity Rotating bar is provided with side relative in second gear, first gear and the second gear intermeshing, the refrigerating box (10) The chute corresponding with roller is equipped with wall, and roller is located in chute, the side of the movable block (12) is connected with folding Plate (13), the one end of the folded sheet (13) away from movable block (12) is fixed on the side wall in refrigerating box (10), described Refrigerating plant is provided with refrigerating box (10).
2. a kind of kit detected for B cell leukemia minimal residual disease according to claim 1, its feature exists In the side of the box body (5) is hinged with loading plate (2), and the side wall of the box body (5) is provided with two coilings being parallel to each other Device (8), the bobbin winoler (8) is provided with drawstring (9), and the one end of the drawstring (9) away from bobbin winoler (8) is fixed on loading plate (2) multiple first standing grooves are equidistantly provided with, on the loading plate (2), the side of first standing groove is provided with two the Two standing grooves, second standing groove is more than the first standing groove.
3. a kind of kit detected for B cell leukemia minimal residual disease according to claim 1, its feature exists In equidistantly provided with multiple upper cushion blocks on relative side wall in the placed cavity, the side of the upper cushion block is fixed with damping bullet Spring (11), the one end of the damping spring (11) away from upper cushion block is fixed with lower cushion block, and one end of the lower cushion block is fixed on cold On the side wall for hiding box (10).
4. a kind of kit detected for B cell leukemia minimal residual disease according to claim 1, its feature exists In the lid (1) is provided with stopper slot (4), the stopper slot (4) and is hinged with handle (3), and the handle (3) is provided with Anti-slip veins.
5. a kind of kit detected for B cell leukemia minimal residual disease according to claim 1, its feature exists In being equipped with heat-insulation layer on the side wall in the refrigerating box (10).
CN201720025086.2U 2017-01-10 2017-01-10 A kind of kit detected for B cell leukemia minimal residual disease Expired - Fee Related CN206476981U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201720025086.2U CN206476981U (en) 2017-01-10 2017-01-10 A kind of kit detected for B cell leukemia minimal residual disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201720025086.2U CN206476981U (en) 2017-01-10 2017-01-10 A kind of kit detected for B cell leukemia minimal residual disease

Publications (1)

Publication Number Publication Date
CN206476981U true CN206476981U (en) 2017-09-08

Family

ID=59750684

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201720025086.2U Expired - Fee Related CN206476981U (en) 2017-01-10 2017-01-10 A kind of kit detected for B cell leukemia minimal residual disease

Country Status (1)

Country Link
CN (1) CN206476981U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115465572A (en) * 2022-09-02 2022-12-13 湖南省产商品质量检验研究院 Rapid detection kit for pesticide residues and use method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115465572A (en) * 2022-09-02 2022-12-13 湖南省产商品质量检验研究院 Rapid detection kit for pesticide residues and use method thereof

Similar Documents

Publication Publication Date Title
CN206300444U (en) A kind of endocrine censorship test tube sterilizing and drying device
US20110114877A1 (en) Plasmid DNA Isolation
CN206476981U (en) A kind of kit detected for B cell leukemia minimal residual disease
CN107249746A (en) System and method for collecting sample of nucleic acid
CN206474208U (en) A kind of practical clinical examination rack for test tube
CN109929813A (en) Salmonella bacteriophage nanometer magnetic bead conjugate and its concentration and separation kit
CN107512724A (en) One kind is used to remove CO in admixture of gas2Silica zeolite
CN207760321U (en) The reagent disc of pre-treatment is automated for detection of nucleic acids
CN208869582U (en) The micro-fluidic chip of bacterium total nucleic acid in a kind of extraction human whole blood
CN206529458U (en) A kind of kit detected for T cell Minimal Residual Disease of Leukemia
CN107603975A (en) A kind of lily method for extracting total RNA
CN110699243B (en) Multifunctional nucleic acid detection device
CN103898191B (en) Detection Methods of Salmonella and detection substratum
CN209514935U (en) A kind of bioconversion medium sample displaying device
CN207641522U (en) A kind of test device of medical test
CN208658280U (en) A kind of chemical reagent storing compartment
CN207970897U (en) A kind of centrifuge tube extraction plate
Wang et al. Use of automated riboprinter and pulsed-field gel electrophoresis for epidemiological studies of invasive Haemophilus influenzae in Taiwan
CN209401184U (en) A kind of medical teaching parasite specimen displaying device
CN206375908U (en) A kind of low temperature hybridization instrument
CN211984573U (en) Categorised specimen cabinet
CN108034581A (en) A kind of device for being used to detect detection of Salmonella
CN215664635U (en) ARGs absolute quantitative kit suitable for 96-channel qPCR instrument
CN220967410U (en) Nursing medicine chest
CN216071059U (en) Rotavirus detection kit in intestinal tract

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170908

Termination date: 20210110